Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
1.560
-0.005 (-0.32%)
Mar 4, 2026, 4:00 PM EST - Market closed
Daré Bioscience Market Cap
Daré Bioscience has a market cap or net worth of $22.29 million as of March 5, 2026. Its market cap has decreased by -15.56% in one year.
Market Cap
22.29M
Enterprise Value
2.15M
1-Year Change
-15.56%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since April 10, 2014, Daré Bioscience's market cap has decreased from $98.00M to $22.29M, a decrease of -77.25%. That is a compound annual growth rate of -11.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 22.30M | -19.20% |
| Dec 31, 2025 | 27.60M | 1.85% |
| Dec 31, 2024 | 27.10M | -11.15% |
| Dec 29, 2023 | 30.50M | -56.68% |
| Dec 30, 2022 | 70.40M | -54.05% |
| Dec 31, 2021 | 153.20M | 200.98% |
| Dec 31, 2020 | 50.90M | 271.53% |
| Dec 31, 2019 | 13.70M | 69.14% |
| Dec 31, 2018 | 8.10M | -38.17% |
| Dec 29, 2017 | 13.10M | -32.47% |
| Dec 30, 2016 | 19.40M | -74.67% |
| Dec 31, 2015 | 76.60M | -38.82% |
| Dec 31, 2014 | 125.20M | 27.76% |
| Apr 10, 2014 | 98.00M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Barinthus Biotherapeutics | 24.99M |
| Skye Bioscience | 24.84M |
| Lixte Biotechnology Holdings | 24.48M |
| Senti Biosciences | 24.33M |
| Marker Therapeutics | 23.67M |
| Vistagen Therapeutics | 23.55M |
| Exicure | 23.36M |
| Neuphoria Therapeutics | 23.34M |